Frovatriptan
FROVATRIPTAN
NADAC/unit
$3.1675
No Shortage
Tier 1: 0.6%
4 Manufacturers
4 ANDAs
vs. brand FROVATRIPTAN: Generic saves up to 68% per unit
Active Shortages
2026-02-24 A business decision was made to discontinue manufacture of the drug., Endo Pharmaceuticals, Inc.
2025-11-12 A business decision was made to discontinue manufacture of the drug., Endo Pharmaceuticals, Inc.
Market Intelligence
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
AMNEAL PHARMACEUTICALS CO GMBHGLENMARK PHARMACEUTICALS LTDLEADING PHARMA LLCRENATA PLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
